Cardinal Health, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Jason Hollar
- Full Time Employees
- 61,344
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 7000 Cardinal Place Dublin OH United States of America 43017
- IPO Date
- Aug 4, 1983
- CIK
- 0000721371
- Website
- cardinalhealth.com
- Similar Companies
- Business
- Cardinal Health, Inc. (NYSE: CAH) provides integrated healthcare services and products, distributing pharmaceuticals and medical supplies to hospitals, pharmacies, and healthcare providers worldwide. The company manufactures branded and private-label medical, surgical, and laboratory products, including masks, gloves, gowns, and exam apparel under brands such as Aspen Surgical, Cardinal Health, and Trudell; offers nuclear pharmacy services, patient safety solutions, and pharmacy management software; and operates through three main segments: Pharmaceutical, Medical, and Home Health & Hospice. Its product portfolio encompasses over 20,000 national brand pharmaceuticals, over 2,000 generic drugs, and a broad range of medical-surgical supplies like needles, syringes, IV sets, and wound care items; services include third-party logistics, specialty pharmaceutical distribution, and proprietary navigation technology for at-home care. Cardinal Health serves independent retail pharmacies, chains, hospitals, ambulatory surgery centers, clinical laboratories, and physician offices primarily in the United States, Canada, and Puerto Rico, with headquarters in Dublin, Ohio, where it was founded in 1971. In recent developments, Cardinal Health completed the acquisition of Integrated Pharmacy Solutions in October 2024, expanding its 503A sterile compounding capabilities to support hospital pharmacies nationwide; launched a new Advanced Call Center in July 2024 to enhance customer service for its Medical segment; and announced a strategic distribution agreement with the Novo Nordisk Patient Assistance Program (PAP) in November 2024 to broaden access to essential medications. The company also secured a five-year Pharmaceutical Supply Agreement with the U.S. Department of Veterans Affairs in September 2024 valued at approximately $9.3 billion, reinforcing its position as a key government supplier; introduced the Cordless Navigation System for orthopedic procedures in 2024; and completed the divestiture of its Health Care Compliance business to RLDatix in December 2024. These moves reflect ongoing efforts to optimize operations, grow in high-margin areas like sterile compounding and navigation technology, and strengthen partnerships amid supply chain challenges.
Company News
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Should Value Investors Buy Cardinal Health (CAH) Stock?
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know
Cardinal Health, Inc. $CAH Position Decreased by Park National Corp OH
MassMutual Private Wealth & Trust FSB Buys 106,709 Shares of Cardinal Health, Inc. $CAH
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5
Cardinal Health: I'm Still Buying After Checking The Numbers
At-Home Healthcare Is Growing Fast: Can CAH Ride the Trend?
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?
Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now?
Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?
Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds